Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Retained Earnings: 2017-2025

Historic Retained Earnings for Autolus Therapeutics (AUTL) over the last 6 years, with Sep 2025 value amounting to -$1.3 billion.

  • Autolus Therapeutics' Retained Earnings fell 20.98% to -$1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 billion, marking a year-over-year decrease of 20.98%. This contributed to the annual value of -$1.1 billion for FY2024, which is 25.12% down from last year.
  • Latest data reveals that Autolus Therapeutics reported Retained Earnings of -$1.3 billion as of Q3 2025, which was down 6.50% from -$1.2 billion recorded in Q2 2025.
  • Over the past 5 years, Autolus Therapeutics' Retained Earnings peaked at -$412.5 million during Q1 2021, and registered a low of -$1.3 billion during Q3 2025.
  • For the 3-year period, Autolus Therapeutics' Retained Earnings averaged around -$992.8 million, with its median value being -$989.5 million (2024).
  • Data for Autolus Therapeutics' Retained Earnings shows a maximum YoY tumbled of 54.48% (in 2021) over the last 5 years.
  • Over the past 5 years, Autolus Therapeutics' Retained Earnings (Quarterly) stood at -$521.3 million in 2021, then decreased by 28.55% to -$670.2 million in 2022, then plummeted by 31.09% to -$878.6 million in 2023, then declined by 25.12% to -$1.1 billion in 2024, then dropped by 20.98% to -$1.3 billion in 2025.
  • Its Retained Earnings stands at -$1.3 billion for Q3 2025, versus -$1.2 billion for Q2 2025 and -$1.2 billion for Q1 2025.